Pedro Perez on Deep Vein Thrombosis in 2026: Getting the First Decisions Right
Pedro Perez, Vascular Consultant – PERT and VTE Program Builder at Argon Medical Devices, Inc., shared on LinkedIn:
”Deep Vein Thrombosis in 2026: Getting the First Decisions Right
Even with major advances in treatment, outcomes in deep vein thrombosis (DVT) still depend heavily on early decisions.
Many preventable complications—such as pulmonary embolism, bleeding, recurrence, and long-term leg symptoms—don’t happen because we lack treatment options.
They happen when the early steps aren’t clear or consistent.
A few principles that still matter:
• Assess risk before jumping to testing
• Use blood tests thoughtfully, not automatically
• Imaging should be targeted, not excessive
• Treatment plans should be intentional and reassessed
• The first few months after diagnosis are critical
When DVT is approached in a structured, step-by-step way, outcomes improve and unnecessary interventions can often be avoided.
Clear decision-making early on remains one of the most powerful tools in managing DVT—now and in the years ahead.”
Stay updated with Hemostasis Today.
-
Aug 14, 2026, 18:30Irina Gontschar: What the Epkinly FDA Review Teaches Us About Sponsor Oversight
-
Aug 14, 2026, 18:20Venkata Sagi: Systemic Anticoagulation or Left Atrial Appendage Closure?
-
Aug 14, 2026, 18:02Marios Psychogios: Every Minute Matters in Acute Stroke Care
-
Aug 14, 2026, 17:57Molly Lippold-Meinholz: The Magic of Camp for Kids With Bleeding Disorders
-
Aug 14, 2026, 17:52Will Thomas: Why Dose Every Missed Thromboprophylaxis Matter
-
Aug 14, 2026, 17:42Nandini Pethe: Representing MicroHealth at BDC
-
Aug 14, 2026, 17:30Richard Habis: Hemophilia Does Not Only Affect the Child
-
Aug 14, 2026, 17:00Zahra Safarzadeh: The Critical Role of the Laboratory in Hemophilia Care
-
Aug 14, 2026, 16:39Yuriy Prokopenko: Advancing Hemostasis Through Scientific Collaboration